Lung Disease Clinical Trials

A listing of Lung Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 484 clinical trials
None
Study to Assess Efficacy and Safety of Aclidinium Bromide and Aclidinium Bromide/Formoterol Fumarate in Stabile COPD Patients

fumarate compared with individual components and placebo and Aclidinium bromide compared with Placebo when administered to patients with stable Chronic Obstructive Pulmonary Disease (COPD).

pulmonary function test
bromide
bronchodilator
formoterol
aclidinium bromide
  • 290 views
  • 10 Oct, 2021
  • 71 locations
None
Study Evaluating Safety Tolerability and PK of AMG 757 in Adults With Small Cell Lung Cancer

A study to assess the safety, tolerability, and pharmacokinetics of AMG 757 in Subjects with Small Cell Lung Cancer

cancer chemotherapy
pembrolizumab
metastasis
brain metastases
platinum-based chemotherapy
  • 398 views
  • 06 Oct, 2021
  • 62 locations
None
Chemoradiation With or Without Atezolizumab in Treating Patients With Limited Stage Small Cell Lung Cancer

This phase III trial studies how well chemotherapy and radiation therapy (chemoradiation) with or without atezolizumab works in treating patients with limited stage small cell lung cancer. Drugs

  • 85 views
  • 13 Oct, 2021
  • 355 locations
None
Assessing the Integration of Tobacco Cessation Treatment Into Lung Cancer Screening (LCS)

This randomized controlled trial seeks to evaluate the effectiveness of alternative strategies to integrate smoking cessation interventions into the delivery of low-dose CT (LDCT) lung cancer

Accepts healthy volunteers
  • 3 views
  • 03 Oct, 2021
  • 2 locations
None
Testing the Timing of Pembrolizumab Alone or With Chemotherapy as First Line Treatment and Maintenance in Non-small Cell Lung Cancer

induction with pembrolizumab, pemetrexed and carboplatin followed by pembrolizumab and pemetrexed maintenance in treating patients with stage IV non-squamous non-small cell lung cancer. Immunotherapy with

oophorectomy
aptt
HIV Infection
tyrosine
pemetrexed
  • 231 views
  • 13 Oct, 2021
  • 832 locations
None
Testing the Addition of an Antibody to Standard Chemoradiation Followed by the Antibody for One Year to Standard Chemoradiation Followed by One Year of the Antibody in Patients With Unresectable Stage III Non-Small Cell Lung Cancer

This phase III trial studies how well an antibody (durvalumab) with chemotherapy and radiation therapy (chemoradiation) works in treating patients with stage III non-small cell lung cancer that

tumor cells
gilbert's syndrome
pemetrexed
paclitaxel
alopecia
  • 141 views
  • 13 Oct, 2021
  • 591 locations
None
Screen to Save 2: Rural Cancer Screening Educational Intervention

The purpose of this study is to help the Dartmouth-Hitchcock Norris Cotton Cancer Center and the National Cancer Institute understand how to educate people about cancer screening.

educational intervention
cancer
lung cancer
lung cancer screening
primary cancer
  • 0 views
  • 10 Oct, 2021
  • 1 location
None
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer ALCHEMIST Chemo-IO Study

This phase III ALCHEMIST trial compares the addition of pembrolizumab to usual chemotherapy versus usual chemotherapy for the treatment of stage IIA, IIB IIIA or IIIB non-small cell lung cancer

pembrolizumab
carboplatin
carcinoma
pemetrexed
gemcitabine
  • 136 views
  • 16 Oct, 2021
  • 815 locations
None
Study of Amivantamab a Human Bispecific EGFR and cMet Antibody in Participants With Advanced Non-Small Cell Lung Cancer

combination with standard of care carboplatin and pemetrexed) in 21 day treatment cycle for participants with advanced non-small cell lung cancer (NSCLC).

afatinib
squamous cell carcinoma
carcinoma
platinum-based chemotherapy
tyrosine
  • 0 views
  • 15 Oct, 2021
  • 116 locations
None
An Open-label Study of Encorafenib + Binimetinib in Patients With BRAFV600-mutant Non-small Cell Lung Cancer

BRAFV600E-mutant metastatic non-small cell lung cancer (NSCLC). Patients who are either treatment-nave, OR who have received 1) first-line treatment with standard platinum-based chemotherapy, OR 2) first

kidney function test
measurable disease
stage iv non-small cell lung cancer
metastasis
lung carcinoma
  • 3 views
  • 10 Oct, 2021
  • 295 locations